Documentdetail
ID kaart

doi:10.1007/s00431-024-05552-0...

Auteur
Maritsi, Despoina Dasoula, Foteini Ziv, Amit Bizjak, Maša Balažiová, Barbora Matošević, Matija Yildiz, Mehmet Alpert, Noa Lamot, Lovro Kasapcopur, Ozgur Dallos, Tomáš Uziel, Yosef Toplak, Natasa Heshin-Bekenstein, Merav
Langue
en
Editor

Springer

Categorie

Medicine & Public Health

Jaar

2024

vermelding datum

17-04-2024

Trefwoorden
influenza vaccine juvenile idiopathic arthritis (jia... vaccination uptake children countries study season 2019–2020 diseases influenza children rates jia vaccination uptake vaccine
Metriek

Beschrijving

While most countries provide safe and effective influenza vaccines for at-risk groups, influenza vaccine coverage among children with rheumatic diseases remains uncertain.

This study investigated influenza vaccination rates in children with juvenile idiopathic arthritis (JIA) during the 2019–2020 season and assessed the knowledge and attitudes of caregivers of children with JIA regarding influenza vaccination.

The secondary aims were to identify barriers to vaccination and explore strategies to improve vaccination rates.

A multi-centre, cross-sectional anonymous survey was conducted in 7 countries during the 2019–2020 influenza season to assess the uptake history of influenza vaccination.

Among 287 participants, only 87 (30%) children with JIA received the influenza vaccine during the 2019–2020 season.

Children who were more likely to be vaccinated were those with systemic juvenile idiopathic arthritis (sJIA), a history of previous vaccination and those aware of the vaccination recommendations.

Conversely, children who previously experienced adverse vaccine-related events reported the lowest uptake.

The primary reason for non-vaccination was lack of awareness about the necessity of influenza vaccination.

Conclusion : Despite variations among countries, the uptake of influenza vaccines remains low in children with JIA.

Improving awareness among families about the importance of influenza vaccination may increase vaccination rates in children with rheumatic diseases.

What is Known: • Rheumatic children are at increased risk for influenza infection due to immunosuppressive therapy and immune dysregulation.

• Influenza vaccine is formally recommended to children with rheumatic diseases.

What is New: • This multicentre study showed that influenza vaccine uptake rates remain suboptimal among children with Juvenile Idiopathic Arthritis despite formal recommendations.

• Factors like previous experience with vaccination and information provided by medical professionals via different ways play essential roles in increasing vaccination rates and can contribute to improved health outcomes for these vulnerable children.

Maritsi, Despoina,Dasoula, Foteini,Ziv, Amit,Bizjak, Maša,Balažiová, Barbora,Matošević, Matija,Yildiz, Mehmet,Alpert, Noa,Lamot, Lovro,Kasapcopur, Ozgur,Dallos, Tomáš,Uziel, Yosef,Toplak, Natasa,Heshin-Bekenstein, Merav, 2024, Influenza vaccine uptake in juvenile idiopathic arthritis: a multi-centre cross-sectional study, Springer

Document

Openen

Delen

Bron

Artikelen aanbevolen door ES/IODE AI

Batoclimab as induction and maintenance therapy in patients with myasthenia gravis: rationale and study design of a phase 3 clinical trial
gravis myasthenia study clinical phase baseline improvement mg-adl 340 week trial placebo period mg maintenance qw